{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:09:53Z","timestamp":1778638193122,"version":"3.51.4"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"W1","license":[{"start":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T00:00:00Z","timestamp":1478736000000},"content-version":"vor","delay-in-days":896,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7,1]]},"DOI":"10.1093\/nar\/gku433","type":"journal-article","created":{"date-parts":[[2014,5,30]],"date-time":"2014-05-30T03:49:06Z","timestamp":1401421746000},"page":"W46-W52","source":"Crossref","is-referenced-by-count":64,"title":["DDI-CPI, a server that predicts drug\u2013drug interactions through implementing the chemical\u2013protein interactome"],"prefix":"10.1093","volume":"42","author":[{"given":"Heng","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,5,29]]},"reference":[{"key":"key\n\t\t\t\t20171011193316_B1","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1001\/jama.2008.892","article-title":"Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States","volume":"300","author":"Qato","year":"2008","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171011193316_B2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1365-2710.2002.00434.x","article-title":"GPs\u2019 views on computerized drug interaction alerts: questionnaire survey","volume":"27","author":"Magnus","year":"2002","journal-title":"J. Clin. Pharm. Ther."},{"key":"key\n\t\t\t\t20171011193316_B3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/dmd.31.7.815","article-title":"The conduct of in vitro and in vivo drug-drug interaction studies: a pharmaceutical research and manufacturers of America (PhRMA) perspective","volume":"31","author":"Bjornsson","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"key\n\t\t\t\t20171011193316_B4","doi-asserted-by":"crossref","first-page":"e1002614","DOI":"10.1371\/journal.pcbi.1002614","article-title":"Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions","volume":"8","author":"Duke","year":"2012","journal-title":"PLoS Comput. Biol."},{"key":"key\n\t\t\t\t20171011193316_B5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd2683","article-title":"Mechanisms of drug combinations: interaction and network perspectives","volume":"8","author":"Jia","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"key\n\t\t\t\t20171011193316_B6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(04)01528-1","article-title":"Drug interactions in oncology","volume":"5","author":"Beijnen","year":"2004","journal-title":"Lancet Oncol."},{"key":"key\n\t\t\t\t20171011193316_B7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2174\/138920011795495259","article-title":"Advances in human cytochrome p450 and personalized medicine","volume":"12","author":"Chen","year":"2011","journal-title":"Curr. Drug Metab."},{"key":"key\n\t\t\t\t20171011193316_B8","doi-asserted-by":"crossref","first-page":"e1002998","DOI":"10.1371\/journal.pcbi.1002998","article-title":"Systematic prediction of pharmacodynamic drug-drug interactions through protein-protein-interaction network","volume":"9","author":"Huang","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"key\n\t\t\t\t20171011193316_B9","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1371\/journal.pcbi.0030217","article-title":"In silico elucidation of the molecular mechanism defining the adverse effect of selective estrogen receptor modulators","volume":"3","author":"Xie","year":"2007","journal-title":"PLoS Comput. Biol."},{"key":"key\n\t\t\t\t20171011193316_B10","doi-asserted-by":"crossref","first-page":"e1000387","DOI":"10.1371\/journal.pcbi.1000387","article-title":"Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors","volume":"5","author":"Xie","year":"2009","journal-title":"PLoS Comput. Biol."},{"key":"key\n\t\t\t\t20171011193316_B11","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/msb.2012.26","article-title":"INDI: a computational framework for inferring drug interactions and their associated recommendations","volume":"8","author":"Gottlieb","year":"2012","journal-title":"Mol. Syst. Biol."},{"key":"key\n\t\t\t\t20171011193316_B12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1367-5931(00)00220-9","article-title":"Screening of drug candidates for their drug\u2013drug interaction potential","volume":"5","author":"Rodrigues","year":"2001","journal-title":"Curr. Opin. Chem. Biol."},{"key":"key\n\t\t\t\t20171011193316_B13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1056-8719(01)00119-8","article-title":"Application of in silico approaches to predicting drug\u2013drug interactions","volume":"45","author":"Ekins","year":"2001","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t20171011193316_B14","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1365-2125.2010.03883.x","article-title":"In silico prediction of efavirenz and rifampicin drug-drug interaction considering weight and CYP2B6 phenotype","volume":"71","author":"Rekic","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"key\n\t\t\t\t20171011193316_B15","doi-asserted-by":"crossref","first-page":"D1060","DOI":"10.1093\/nar\/gkq1037","article-title":"PROMISCUOUS: a database for network-based drug-repositioning","volume":"39","author":"von Eichborn","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20171011193316_B16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/amiajnl-2011-000214","article-title":"A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports","volume":"19","author":"Tatonetti","year":"2012","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"key\n\t\t\t\t20171011193316_B17","doi-asserted-by":"crossref","first-page":"e58321","DOI":"10.1371\/journal.pone.0058321","article-title":"Detection of drug-drug interactions by modeling interaction profile fingerprints","volume":"8","author":"Vilar","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171011193316_B18","doi-asserted-by":"crossref","first-page":"e1002016","DOI":"10.1371\/journal.pcbi.1002016","article-title":"Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome\u2013clozapine-induced agranulocytosis as a case study","volume":"7","author":"Yang","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"key\n\t\t\t\t20171011193316_B19","doi-asserted-by":"crossref","first-page":"e9568","DOI":"10.1371\/journal.pone.0009568","article-title":"Identifying unexpected therapeutic targets via chemical-protein interactome","volume":"5","author":"Yang","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171011193316_B20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/1097-0134(20010501)43:2<217::AID-PROT1032>3.0.CO;2-G","article-title":"Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule","volume":"43","author":"Chen","year":"2001","journal-title":"Proteins"},{"key":"key\n\t\t\t\t20171011193316_B21","doi-asserted-by":"crossref","first-page":"W219","DOI":"10.1093\/nar\/gkl114","article-title":"TarFisDock: a web server for identifying drug targets with docking approach","volume":"34","author":"Li","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20171011193316_B22","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1016\/j.ddtec.2013.01.003","article-title":"Proteome-scale docking: myth and reality","volume":"10","author":"Rognan","year":"2013","journal-title":"Drug Discov. Today Technol."},{"key":"key\n\t\t\t\t20171011193316_B23","doi-asserted-by":"crossref","first-page":"e12063","DOI":"10.1371\/journal.pone.0012063","article-title":"A structure-based approach for mapping adverse drug reactions to the perturbation of underlying biological pathways","volume":"5","author":"Wallach","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171011193316_B24","doi-asserted-by":"crossref","first-page":"e1000441","DOI":"10.1371\/journal.pcbi.1000441","article-title":"Harvesting candidate genes responsible for serious adverse drug reactions from a chemical-protein interactome","volume":"5","author":"Yang","year":"2009","journal-title":"PLoS Comput. Biol."},{"key":"key\n\t\t\t\t20171011193316_B25","doi-asserted-by":"crossref","first-page":"W406","DOI":"10.1093\/nar\/gkp312","article-title":"SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical-protein interactome","volume":"37","author":"Yang","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20171011193316_B26","doi-asserted-by":"crossref","first-page":"W492","DOI":"10.1093\/nar\/gkr299","article-title":"DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome","volume":"39","author":"Luo","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20171011193316_B27","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20171011193316_B28","doi-asserted-by":"crossref","first-page":"D684","DOI":"10.1093\/nar\/gkm795","article-title":"STITCH: interaction networks of chemicals and proteins","volume":"36","author":"Kuhn","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20171011193316_B29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/B:JCAM.0000035186.90683.f2","article-title":"VEGA\u2013an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming","volume":"18","author":"Pedretti","year":"2004","journal-title":"J. Comput. Aided Mol. Des."},{"key":"key\n\t\t\t\t20171011193316_B30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20171011193316_B31","doi-asserted-by":"crossref","first-page":"e60368","DOI":"10.1371\/journal.pone.0060368","article-title":"Gene expression variability in human hepatic drug metabolizing enzymes and transporters","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171011193316_B32","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1021\/jm030580l","article-title":"The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures","volume":"47","author":"Wang","year":"2004","journal-title":"J. Med. Chem."},{"key":"key\n\t\t\t\t20171011193316_B33","doi-asserted-by":"crossref","first-page":"bar009","DOI":"10.1093\/database\/bar009","article-title":"UniProt Knowledgebase: a hub of integrated protein data","volume":"2011","author":"Magrane","year":"2011","journal-title":"Database (Oxford)"},{"key":"key\n\t\t\t\t20171011193316_B34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"key\n\t\t\t\t20171011193316_B35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1021\/ci300399w","article-title":"Consensus docking: improving the reliability of docking in a virtual screening context","volume":"53","author":"Houston","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"key\n\t\t\t\t20171011193316_B36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminform."},{"key":"key\n\t\t\t\t20171011193316_B37","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"key\n\t\t\t\t20171011193316_B38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1023\/B:JCAM.0000047813.47656.36","article-title":"Reverse-docking as a computational tool for the study of asymmetric organocatalysis","volume":"18","author":"Harriman","year":"2004","journal-title":"J. Comput. Aided Mol. Des."},{"key":"key\n\t\t\t\t20171011193316_B39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.1158140","article-title":"Drug target identification using side-effect similarity","volume":"321","author":"Campillos","year":"2008","journal-title":"Science"},{"key":"key\n\t\t\t\t20171011193316_B40","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/0006-3223(95)00178-8","article-title":"Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo","volume":"38","author":"Fabre","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"key\n\t\t\t\t20171011193316_B41","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/004982599238290","article-title":"Determination of the human cytochrome P450 isoforms involved in the metabolism of zolmitriptan","volume":"29","author":"Wild","year":"1999","journal-title":"Xenobiotica"},{"key":"key\n\t\t\t\t20171011193316_B42","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1592\/phco.27.8.1189","article-title":"Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome","volume":"27","author":"Narita","year":"2007","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t20171011193316_B43","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00004714-199404000-00010","article-title":"Sertraline and isocarboxazid cause a serotonin syndrome","volume":"14","author":"Brannan","year":"1994","journal-title":"J. Clin. Psychopharmacol."},{"key":"key\n\t\t\t\t20171011193316_B44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1526-4610.2007.00964.x","article-title":"Concomitant triptan and SSRI or SNRI use: a risk for serotonin syndrome","volume":"48","author":"Sclar","year":"2008","journal-title":"Headache"},{"key":"key\n\t\t\t\t20171011193316_B45","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1124\/jpet.102.041921","article-title":"Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A","volume":"304","author":"Shitara","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"key\n\t\t\t\t20171011193316_B46","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1365-2125.2000.00134.x","article-title":"Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions","volume":"49","author":"Ohyama","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"key":"key\n\t\t\t\t20171011193316_B47","doi-asserted-by":"crossref","first-page":"6559","DOI":"10.1073\/pnas.1001460107","article-title":"Mechanism of recognition of compounds of diverse structures by the multidrug efflux pump AcrB of Escherichia coli","volume":"107","author":"Takatsuka","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/42\/W1\/W46\/17423695\/gku433.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T04:52:37Z","timestamp":1716785557000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/nar\/article\/42\/W1\/W46\/2437493\/DDICPI-a-server-that-predicts-drugdrug"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,29]]},"references-count":47,"journal-issue":{"issue":"W1","published-online":{"date-parts":[[2014,5,29]]},"published-print":{"date-parts":[[2014,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gku433","relation":{},"ISSN":["1362-4962","0305-1048"],"issn-type":[{"value":"1362-4962","type":"electronic"},{"value":"0305-1048","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,7,1]]},"published":{"date-parts":[[2014,5,29]]}}}